AACAP+CACAP Joint Annual Meeting
Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.


New Research Poster 2 (open)
New Research Poster Session 2

Thursday, October 20, 2011: 10:00 AM-12:30 PM
 
2.1
Psychiatric Disorders and Stressors Among Under-Aged Married Adolescent Girls Attending in a Child and Adolescent Mental Health Clinic in Dhaka-A Control Comparison Study
Mohammad Sayadul Islam Mullick, M.D. Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhanmondi Residential Area Bangladesh
 
2.2
School Bullying Among Omani Children in Muscat
Marwan Al-Sharbati, M.D. Sultan Qaboos University College of Medicine, Muscat Oman
Syed Gauhar Alam Rizvi, M.D. Sultan Qaboos University, Sultanate of Oman Oman
 
2.3
Committed Suicide Among Turkish and American Youth: A Cross-Cultural Comparison
Murat Coskun, M.D. Women's and Children's Hospital, Trabzon Turkey
Neera Ghaziuddin, M.D. University of Michigan, Ann Arbor, MI
Salih Zoroglu, M.D. Istanbul University, Istanbul Medical Faculty, Istanbul Turkey
 
2.4
Mental Health Survey: Urban Quebec First Generation Tamil Sri Lankan and Bangladeshi Adolescents
Jaswant Guzder McGill University, Jewish General Hospital, Center for Child Development and Mental Health, Montreal, QC
Mariam Haider, D. Phil. McGill University, Jewish General Hospital, Centre for Child Development and Mental Health, Montreal, QC
Ratna Ghosh, D. Phil. Mcgill University, Montreal, QC
 
2.5
Strong Families: Promoting Resilience in Military Families
Sheila M. Marcus, M.D. University of Michigan, Ann Arbor, MI
Katherine Lisa Rosenblum, Ph.D. University of Michigan, Ann Arbor, MI
Tom Fluent, M.D. University of Michigan, Plymouth, MI
 
2.6
Parent Cultural Attitudes and Beliefs Regarding Young Children and Television
Wanjiku F.M. Njoroge, M.D. University of Washington School of Medicine, Seattle, WA
Laura Elenbaas, B.A. Seattle Children's Research Institute, Center for Child Health, Behavior and Development, Seattle, WA
Mon Thiri Myiang, Ph.D. Center for Child Health, Behavior, and Development, Seattle, WA
Dimitri Christakis, M.D., M.P.H. University of Washington School of Medicine, Department of Pediatrics, Seattle, WA
 
2.7
Non-Governmental Organization (NGO) Collaboration to Adapt Psychological First Aid Training for Japan: Changes in Participants' Perceived Confidence
Inka Weissbecker, M.P.H., Ph.D. International Medical Corps, Washington, DC
Linda Semlitz, M.D. Tokyo English Life Line, Tokyo Japan
Elizabeth B. Gilbert, B.A. Warren Alpert Medical School at Brown University, Providence, RI
 
2.10
Characteristics of the Child Behavioral Checklist in Adolescents with Depression Associated with Bipolar Disorder
Arman Danielyan, M.D. Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Jeffrey Welge, Ph.D. University of Cincinnati, Cincinnati USA
Shaohong Zheng, M.B.A. University of Cincinnati, Cincinnati, OH
Caleb M. Adler, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
Kiki D. Chang, M.D. Stanford University School of Medicine, Palo Alto, CA
Melissa P. DelBello, M.D., M.S. University of Cincinnati College of Medicine, Cincinnati, OH
 
2.11
Exploratory Factor Analysis of the CDRS-R with Depressed Adolescents
Allison Clarke, B.S. Northwestern University, Chicago, IL
Lindsey S. Sankin, B.A. Northwestern University, Chicago, IL
William Jeffrey Canar, Ph.D. Edward Hines, Jr. VA Hospital, Hines, IL
Mark A. Reinecke, Ph.D. Northwestern University, Chicago, IL
 
2.12
Longitudinal Effects of Comorbid Anxiety Disorders in Children and Adolescents with Bipolar Spectrum Disorders
Regina Sala, M.D. New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, New York, NY
David Axelson, M.D. University of Pittsburgh Medical Center; Western Psychiatric Institute and Clinic, Pittsburgh, PA
Josefina Castro-Fornieles, M.D., Ph.D. IDIBAPS, CIBERSAM, Neurosciences Institute, Universitat de Barcelona, Barcelona Spain
Tina R. Goldstein, Ph.D. University of Pittsburgh, Pittsburgh, PA
Benjamin I. Goldstein, M.D., FRCPC, Ph.D. Sunnybrook Health Sciences Centre, Toronto, ON
Wonho Ha, Ph.D. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA
Fangzi Liao, M.S. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA
Mary Kay Gill, M.S., R.N. University of Pittsburgh Medical Center, Pittsburgh, PA
Satish Iyengar, Ph.D. University of Pittsburgh, Pittsburgh, PA
Michael Strober, Ph.D. University of California, Los Angeles, Los Angeles, CA
Shirley Yen, Ph.D. The Warren Alpert Medical School at Brown University, Providence, RI
Heather Meg Hower, M.S.W. The Warren Alpert Medical School at Brown University, Providence, RI
Jeffrey Hunt, M.D. The Warren Alpert Medical School of Brown University, Riverside, RI
Daniel P. Dickstein, M.D. Bradley Hospital, East Providence, RI
Neal D. Ryan, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Martin Keller, M.D. Brown University, Providence, RI
Boris Birmaher, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
 
2.13
Quality of Depression Treatment for Medicaid Insured Youth
Bradley D. Stein, M.D., Ph.D. University of Pittsburgh School of Medicine, Pittsburgh, PA
Jane N. Kogan, Ph.D. University of Pittsburgh School of Medicine, Pittsburgh, PA
Upasna Goswami, M.S. University of Pittsburgh School of Medicine, Pittsburgh, PA
Mark J. Sorbero, M.S. University of Pittsburgh Medical Center, Pittsburgh, PA
Carrie M. Farmer, Ph.D. RAND Corporation, Pittsburgh, PA
 
2.14
Decreased Conflict Driven Adaptation in Individuals At Familial Risk for Developing Bipolar Disorder
Luis R. Patino, M.D., M.S. University of Cincinnati, Cincinnati, OH
Caleb M. Adler, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
Neil P. Mills, B.S. University of Cincinnati College of Medicine, Cincinnati, OH
Stephen Strakowski, M.D. University of Cincinnati College of Medicine, Cincinnati, OH
David Fleck, Ph.D. University of Cincinnati, Cincinnati, OH
Jeffrey Welge, Ph.D. University of Cincinnati, Cincinnati USA
Melissa P. DelBello, M.D., M.S. University of Cincinnati College of Medicine, Cincinnati, OH
 
2.15
Predicting Self-Injurious Behavior and Suicidal Ideation in Adolescents: Mixed and Depressive Moods As Risk Factors
Michael W. Willis Jr., B.A. University of North Carolina at Chapel Hill, Chapel Hill, NC
Anna R. Van Meter, M.A. University of North Carolina at Chapel Hill, Chapel Hill, NC
Andrew Freeman, M.A. University of North Carolina at Chapel Hill, Chapel Hill, NC
Eric Youngstrom, Ph.D. University of North Carolina at Chapel Hill, Chapel Hill, NC
 
2.16
Suicidality in Pediatric Bipolar Disorder: Psychosocial Correlates and Targets for Treatment
Sally Weinstein, Ph.D. Institute for Juvenile Research, Chicago, IL
Amy Elizabeth West, Ph.D. University of Illinois at Chicago, Chicago, IL
Mani N. Pavuluri, M.D., F.R.A.N.Z.C.P., Ph.D. Institute for Juvenile Research, Pediatric Brain Research and Intervention Center, Chicago, IL
 
2.17
Treatments, Services, and Quality of Care in Children Diagnosed with Bipolar Disorder: A First Report
Jennifer L. Vande Voort, M.D. Mayo Clinic, Rochester, MN
Cosima Swintak, M.D. Mayo Clinic, Rochester, MN
Christopher A. Wall, M.D. Mayo Clinic, Rochester, MN
Peter S. Jensen, M.D. Mayo Clinic; The REACH Institute, New York, NY
 
2.18
Random Forests Screening of Baseline Characteristics to Predict Efficacy and Safety/Tolerability of Aripiprazole in Pediatric Patients with Bipolar I Disorder
Joan Zhao, Ph.D. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ
Kiki D. Chang, M.D. Stanford University School of Medicine, Palo Alto, CA
Eric Youngstrom, Ph.D. University of North Carolina at Chapel Hill, Chapel Hill, NC
Benjamin I. Goldstein, M.D., FRCPC, Ph.D. Sunnybrook Health Sciences Centre, Toronto, ON
Ron Marcus, M.D. Bristol-Myers Squibb, Wallingford, CT
Robert D. McQuade, Ph.D. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ
Robert A. Forbes, Ph.D. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ
Candace Andersson, Ph.D. Bristol-Myers Squibb, Plainsboro, NJ
Diane Ammerman, Pharm.D. Bristol-Myers Squibb, Plainsboro, NJ
Elizabeth Bellocchio, Ph.D. Bristol-Myers Squibb, Sacramento, CA
Maia Miguelez, Ph.D. Bristol-Myers Squibb Canada, St-Laurent, QC
Ray Mankoski, M.D., Ph.D. Bristol-Myers Squibb, Plainsboro, NJ
 
2.19
Impulsivity Predicts Poor Symptom Improvement in Pediatric Depression SSRI-Treatment
Fadi Maalouf, M.D. American University of Beirut, Beirut Lebanon
Mia M. Atwi, B.A. American University of Beirut, Beirut Lebanon
Lucy Tawitian, B.A. American Univeristy of Beirut, Beirut Lebanon
Mary L. Phillips, M.D. University of Pittsburgh School of Medicine, Pittsburgh, PA
David A. Brent, M.D. University of Pittsburgh, Pittsburgh, PA
 
2.20
A Double-Blind, Placebo-Controlled Study of Selegiline Transdermal System (STS) in Depressed Adolescents
Melissa P. DelBello, M.D., M.S. University of Cincinnati College of Medicine, Cincinnati, OH
Thomas J. Hochadel, Pharm.D. Cognitive Research Corporation, Saint Petersburg, FL
Kimberly B. Portland, Ph.D. Dey Pharma, L. P., Basking Ridge, NJ
Sunil Mehra, M.D. Dey Pharma, L. P., Basking Ridge, NJ
Arif Khan, M.D. Northwest Clinical Research Center, Bellevue, WA
Alain Katic, M.D. , Houston, TX
Graham J. Emslie, M.D. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
2.21
Association Between Media Use in Adolescence and Depression
Anna Georgiopoulos, M.D. Harvard Medical School, Boston, MA
Brian Primack, M.D., Ed.D., M.S. University of Pittsburgh School of Medicine, Pittsburgh, PA
 
2.22
Vitamin D Levels, Depression, and Physical Health in Children and Adolescents
Barbara L. Gracious, M.D. The Ohio State University, Columbus, OH
 
2.23
Age-Adjusted Prevalence Rates of Lifetime Psychopathology in Youth At High and Low Genetic Risk of Bipolar Disorder: Updated Findings From a Longitudinal Prospective Study
Amanda Helleman, B.A. Mood Disorders Centre of Ottawa, Ottawa, ON
Marisa Murray, B.A. Mood Disorders Centre of Ottawa, Ottawa, ON
Sarah Margaret Doucette, B.S. Dalhousie University, Halifax, NS
Julie Horrocks, Ph.D. University of Guelph, Guelph, ON
Gregory Persson, B.S. University of Guelph, Guelph, ON
Paul Grof, M.D., Dr.P.H., FRCPC Mood Disorders Centre of Ottawa, Ottawa, ON
Anne Duffy, M.D., FRCPC, M.S.C. Dalhousie University, Halifax, NS
 
2.24
Neurobiological, Genetic, and Phenomenological Risk-Factors Associated with Antidepressant-Induced Mania in Youth At High Risk for Bipolar Disorder
Meghan E. Howe, L.C.S.W., M.S.W. Stanford University, Stanford, CA
Elizabeth Addams, B.S. Stanford University, Stanford, CA
Nicole N. Adams Stanford University School of Medicine, Stanford, CA
Amy Garrett, Ph.D. Stanford University School of Medicine, Stanford, CA
Joachim Hallmayer, M.D. Stanford University, Stanford, CA
Manpreet K. Singh, M.D. Stanford University School of Medicine, Stanford, CA
Kiki D. Chang, M.D. Stanford University School of Medicine, Palo Alto, CA
 
2.25
Irritability without Elation in a Large Bipolar Youth Sample: Clinical Outcomes At 48 Months
Jeffrey Hunt, M.D. The Warren Alpert Medical School of Brown University, Riverside, RI
Boris Birmaher, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Daniel P. Dickstein, M.D. Bradley Hospital, East Providence, RI
Robert Stout, Ph.D. Pacific Institute for Research and Evaluation, Pawtucket, RI
Shirley Yen, Ph.D. The Warren Alpert Medical School at Brown University, Providence, RI
Heather Meg Hower, M.S.W. The Warren Alpert Medical School at Brown University, Providence, RI
David Axelson, M.D. University of Pittsburgh Medical Center; Western Psychiatric Institute and Clinic, Pittsburgh, PA
Neal D. Ryan, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Tina R. Goldstein, Ph.D. University of Pittsburgh, Pittsburgh, PA
Benjamin I. Goldstein, M.D., FRCPC, Ph.D. Sunnybrook Health Sciences Centre, Toronto, ON
Michael Strober, Ph.D. University of California, Los Angeles, Los Angeles, CA
Martin Keller, M.D. Brown University, Providence, RI
 
2.26
Impact of Insomnia in Youth with Major Depressive Disorder
Ameena O. Isa, M.D. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Jessica D. King, B.A. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Taryn Mayes, M.S. University of Texas Southwestern Medical Center at Dallas, Flower Mound, TX
Betsy D. Kennard, Psy.D. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Paul Nakonezny, Ph.D. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Paul E. Croarkin, D.O. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Jodi Mahoney, B.S. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Graham J. Emslie, M.D. University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
2.27
Cognitive Deficits in Euthymic Adolescents with Bipolar Disorder
Vivian Kafantaris, M.D. The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY
Chaya B. Gopin, Ph.D. North Shore-Long Island Jewish Health System, Glen Oaks, NY
Nikki J. Katsiotas, B.A. North Shore-Long Island Jewish Health System, Glen Oaks, NY
Michele L. Gonen, M.A. North Shore-Long Island Jewish Health System, Glen Oaks, NY
Katherine E. Burdick, Ph.D. Mount Sinai School of Medicine, New York, NY
 
2.28
The Life Event Browser for Longitudinal Monitoring of Life Events in Teens with Self-Reported Mood Swings: Early Results
David M. Kreindler, M.D., FRCPC Sunnybrook Health Sciences Centre, Toronto, ON
Charles J. Lumsden, Ph.D. University of Toronto, Toronto, ON
Nicholas Woolridge, M.S.C. University of Toronto, Mississauga, ON
Anthony Levitt, M.D., FRCPC Sunnybrook Health Sciences Centre, Toronto, ON
Jasna E. Deluce, B.S. Sunnybrook Health Sciences Centre, Toronto, ON
 
2.29
Effect of Family Environment on Behavioral Problems in Youth At High Risk for Bipolar Disorder
Sherrie Li, B.A. Stanford University School of Medicine, Stanford, CA
Victoria E. Cosgrove, Ph.D. Stanford University School of Medicine, Stanford, CA
Nicole N. Adams Stanford University School of Medicine, Stanford, CA
Tenah K. Acquaye, B.A. Stanford University, Stanford, CA
Elizabeth G. Adams Stanford University School of Medicine, Stanford, CA
Virginia R. Shoemaker, B.A. Stanford University School of Medicine, Stanford, CA
Meghan E. Howe, L.C.S.W., M.S.W. Stanford University, Stanford, CA
Kiki D. Chang, M.D. Stanford University School of Medicine, Palo Alto, CA
 
2.30
A Multi-Layered Assessment Approach to Decrease False Diagnosis Rates of Pediatric Bipolar Disorder in the Hospital Setting: Preliminary Data From the Nation's First Pediatric Bipolar Disorder Inpatient Program
Rasim Somer Diler, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
David Axelson, M.D. University of Pittsburgh Medical Center; Western Psychiatric Institute and Clinic, Pittsburgh, PA
Boris Birmaher, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Jessica Singer, R.N. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Kim Owens, Dr.P.H. Western Psychiatric Instutute and Clinic, Pittsburgh, PA
Frank Depietro, M.D., Ph.D. University of Pittsburgh Medical Center, Pittsburgh, PA
Martin J. Lubetsky, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Ken Nash, M.D. University of Pittsburgh Medical Center, Pittsburgh, PA
Sheri Goldstrohm, Ph.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Tina R. Goldstein, Ph.D. University of Pittsburgh, Pittsburgh, PA
Kathy Scheuble, L.C.S.W. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Jamie L. Fernandez, R.N. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Dominic Atwater, L.S.W. Western Psychiatric Institute and Clinic, Pittsburgh, PA
Jessica Tintera, M.S.W. Western Psychiatric Institute and Clinic, Pittsburgh, PA
 
2.31
Cardiovascular Differences in Children with Autism Spectrum Disorders and Controls During the Autism Diagnostic Observation Schedule (ADOS)
Victoria Hallett, Ph.D. Yale University, New Haven, CT
Angelica Ronald, Ph.D. Birkbeck University, London United Kingdom
Marianne Keenan, M.S.C. University College London, London United Kingdom
Lawrence Scahill, M.S.N., Ph.D. Yale Child Study Center, New Haven, CT
Francesca Happé, Ph.D. Institute of Psychiatry, Kings College London, Denmark Hill United Kingdom
 
2.32
Target Symptoms of Most Concern to Parents of Preschool Children with Pervasive Developmental Disorders Responding to Methylphenidate
Jaswinder K. Ghuman, M.D. University of Arizona, Tucson, AZ
Seenaiah Byreddy, M.D. University of Arizona, Tucson, AZ
Harinder S. Ghuman, M.D. University of Arizona, Tucson, AZ
 
2.33
Validation of Proposed DSM-5 Criteria for Autism Spectrum Disorder
Thomas W. Frazier, Ph.D. Cleveland Clinic, Cleveland, OH
Eric Youngstrom, Ph.D. University of North Carolina at Chapel Hill, Chapel Hill, NC
Leslie Speer, Ph.D. Cleveland Clinic, Cleveland, OH
Rebecca Embacher Cleveland Clinic, Cleveland, OH
Paul Law, M.D., M.P.H. Kennedy Krieger Institute, Baltimore, MD
John N. Constantino, M.D. Washington University School of Medicine in St. Louis, Saint Louis, MO
Robert L. Findling, M.D. University Hospitals Case Medical Center, Cleveland, OH
Antonio Hardan, M.D. Stanford University, Stanford, CA
Charis Eng, M.D., Ph.D. Cleveland Clinic, Cleveland, OH
 
2.34
Rapid Observational Confirmation of Autistic Syndromes
John N. Constantino, M.D. Washington University School of Medicine in St. Louis, Saint Louis, MO
 
2.35
The Reliability and Validity of the Social Responsiveness Scale (SRS) - Korean Version in a Normal Population: Clinical and Epidemiological Sample
Keun-Ah Cheon, M.D., Ph.D. Severance Children's Hospital, Yosei University College of Medicine, Seoul South Korea
JeeIn Park, M.D. Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Yun-Joo Koh, Ph.D. The Korea Institute for Children's Social Development, Seoul South Korea
Jungeun Song, M.D. Myungji Hospital, Kwandong University, Goyang Si South Korea
Hyun Ju Hong, M.D. Hallym University Sacred Heart Hospital, Anyang Kyunggi-do South Korea
Young-Key Kim, M.D. National Health Insurance Corporation Ilsan Hospital, Seoul South Korea
Eun-Chung Lim, M.A. The Korea Institute for Children's Social Development; Rudolph Child Research Center South Korea
Hojang Kwon, M.D. South Korea
Mina Ha, M.D. South Korea
Myung-Ho Lim, M.D. Dankook University College of Medicine South Korea
Ki-Chung Paik, M.D. Dankook University College of Medicine South Korea
Kyungun Jhung, M.D. Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Jinkook Heo, M.D. Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Dong-Ho Song, M.D., Ph.D. Severance Children's Hospital, Yosei University College of Medicine, Seoul South Korea
Bennett L. Leventhal, M.D. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
Young-Shin Kim, M.D., M.P.H., M.S., Ph.D. Yale Child Study Center, Branford, CT
 
2.36
Event-related Potential (ERP) Correlates of Impulsivity: Inhibitory Control in Children with an Autism Spectrum Disorder
Melisa Carrasco, M.S. University of Michigan, Ann Arbor, MI
Gregory L. Hanna, M.D. University of Michigan, Ann Arbor, MI
Catherine Lord, Ph.D. Weill Cornell Medical College; New York Presbyterian Hospital, New York, NY
William J. Gehring, Ph.D. University of Michigan, Ann Arbor, MI
 
2.37
Aripiprazole for the Long Term Treatment of Disruptive Behaviors in Autism
Terrence C. Bethea, M.D. University of North Carolina at Chapel Hill, Burlington, NC
Jennifer Richards, M.D., M.B.A. University of North Carolina at Chapel Hill, Durham, NC
Cheryl Alderman, B.S. University of North Carolina at Chapel Hill, Chapel Hill, NC
Michelle Bates, B.A. University of North Carolina at Chapel Hill, Chapel Hill, NC
Linmarie Sikich, M.D. University of North Carolina at Chapel Hill, Chapel Hill, NC
 
2.38
Maternal Depression and Reports of Child Autism Spectrum Disorder Behaviors: Shared Versus Unique Associations
Teresa A. Bennett, M.D., FRCPC McMaster University, Offord Centre for Child Studies, Hamilton, ON
Michael Boyle, Ph.D. McMaster University, Hamilton, ON
Katholiki Georgiades, Ph.D. McMaster University, Hamilton, ON
Stelios Georgiades, M.A. McMaster University, Offord Centre for Child Studies, Hamilton, ON
Ann P. Thompson, B.S. McMaster University, Offord Centre for Child Studies, Hamilton, ON
Eric Duku McMaster University, Offord Centre for Child Studies, Hamilton, ON
Susan Bryson Stanford University, Stanford, CA
Eric Fombonne McGill University, Montreal Children's Hospital, Montreal, QC
Pat Mirenda, Ph.D. University of British Colubmia, Vancouver, BC
Wendy Roberts The Hospital for Sick Children, Toronto, ON
Isabel M. Smith, Ph.D. Izaak Walton Killam Health Centre, Dalhousie University, Halifax, NS
Tracy Vaillancourt, Ph.D. University of Ottawa, Ottawa, ON
Joanne Volden University of Alberta, Edmonton, AB
Charlotte Waddell, M.D., FRCPC Simon Fraser University, Vancouver, BC
Lonnie Zwaigenbaum, M.D. Glenrose Rehabilitation Hospital, Edmonton, AB
Peter Szatmari, M.D. McMaster University, Hamilton, ON
 
2.39
Sapropterin As a Treatment for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Glen R. Elliott, M.D., Ph.D. Children's Health Council, Palo Alto, CA
Cheryl Klaiman, Ph.D. Children's Health Council, Palo Alto, CA
Lauren M. Masaki, B.A. Children's Health Council, Palo Alto, CA
Lynne C. Huffman, M.D. Stanford University, Palo Alto, CA
 
2.40
Weight Gain and Metabolic Changes in Studies of Aripiprazole for the Treatment of Irritability Associated with Autistic Disorder
Stephen Murray, M.B.A., Pharm.D. Bristol-Myers Squibb, Plainsboro, NJ
Joan Zhao, Ph.D. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ
George Manos, Ph.D. Bristol-Myers Squibb, Wallingford, CT
Ray Mankoski, M.D., Ph.D. Bristol-Myers Squibb, Plainsboro, NJ
Ron Marcus, M.D. Bristol-Myers Squibb, Wallingford, CT
Robert D. McQuade, Ph.D. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ
Sabrina V. Marler, M.S. Bristol-Myers Squibb, Wallingford, CT
Robert A. Forbes, Ph.D. Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ
Christoph U. Correll, M.D. The Zucker Hillside Hospital, Glen Oaks, NY
 
2.41
Cognitive Behavioral Therapy for Irritability and Disruptive Behavior in High-Functioning Autism: Pilot Study of Neurobiological Mechanisms
Denis G. Sukhodolsky, Ph.D. Yale School of Medicine, Child Study Center, New Haven, CT
Danielle Bolling, B.A. Yale University, New Haven, CT
Jia Wu, Ph.D. Yale University, New Haven, CT
Michael Crowley, Ph.D. Yale University, New Haven, CT
James McPartland, Ph.D. Yale University, New Haven, CT
Lawrence Scahill, M.S.N., Ph.D. Yale Child Study Center, New Haven, CT
Kevin Pelphrey, Ph.D. Yale University, New Haven, CT
 
2.42
The Multi-Media Social Skills Projects for Adolescents with Autism Spectrum Disorders
Michael Murray, M.D. Penn State Hershey, Hershey, PA
Amanda Pearl, Ph.D. Penn State Hershey, Hershey, PA
Jolene Hillwig Garcia, M.D. Penn State Hershey, Hershey, PA
Laura Smith, B.A. Penn State Hershey, Hershey, PA
 
2.43
Risk of School Bullying in Children with Autism Spectrum Disorder: Based on a Total Population Sample Study
Soonjo Hwang, M.D. Massachusetts General Hospital; Harvard Medical School, Somerville, MA
Young-Shin Kim, M.D., M.P.H., M.S., Ph.D. Yale Child Study Center, Branford, CT
Yun-Joo Koh, Ph.D. The Korea Institute for Children's Social Development, Seoul South Korea
Eun-Chung Lim, M.A. The Korea Institute for Children's Social Development; Rudolph Child Research Center South Korea
Bo Young Song, M.A. The Korea Institute for Children's Social Development, Seoul South Korea
Bennett L. Leventhal, M.D. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY
 
2.44
Association Between Parental Psychiatric Disorders and Autism Spectrum Disorders (ASD)
Elina Katariina Jokiranta, M.S.C. University of Turku, Turku Finland
Markus Heinimaa, M.D., Ph.D. University of Turku, Turku Finland
Auli Partanen, M.S.C. University of Turku, Turku Finland
Alan S. Brown, M.D., M.P.H. New York State Psychiatric Institute, New York, NY
Andre Sourander, M.D. University of Turku, Turku Finland
 
2.45
Multimodal Emotion Processing in High-Functioning Autism: An Event-Related Potentials Study
Matthew D. Lerner, M.A. University of Virginia, Charlottesville, VA
James P. Morris, Ph.D. University of Virginia, Charlottesville, VA
 
2.46
Eyeblink Conditioning in Children with Autism Spectrum Disorders
Richard P. Malone, M.D. Drexel University College of Medicine, Philadelphia, PA
Manely Ghaffari, M.D. Drexel University College of Medicine, Philadelphia, PA
Susan Hyman West, Ph.D. Drexel University College of Medicine, Philadelphia, PA
Beeta Verma, M.D. Drexel University College of Medicine, Philadelphia, PA
Jeff Oristaglio, Ph.D. Drexel University College of Medicine, Philadelphia, PA
John P. Welsh, Ph.D. University of Washington; Seattle Childrens Research Institute, Seattle, WA
 
2.47
Cognition in Patients with Asperger Syndrome, Patients with Early Onset Psychosis, and Healthy Controls: Preliminary Results
Jessica Merchán-Naranjo, M.S.C. Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Concha Bailón, M.S. Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Marta Rapado-Castro, Ph.D. Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Celso Arango, M.D., Ph.D. Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
Mara Parellada, M.D., Ph.D. Hospital General Universitario Gregorio Marañon de Madrid, Centro de Investigación Biomedica en Red de Salud Mental, CIBERSAM, Madrid Spain
 
2.48
Dosing of Risperidone in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study
Stuart Kushner, M.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Xiaoping Ning, M.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Keith Karcher, M.S. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Seth Ness, M.D., Ph.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Michael Aman, Ph.D. The Ohio State University, Columbus, OH
Jaskaran Singh, M.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
David Hough, M.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Gahan Pandina, Ph.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
Justine Kent, M.D. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Titusville, NJ
 
2.49
Effects of an Extended Release Methylphenidate Treatment Regimen on Cognitive Task Performance in Children with Autism Spectrum Disorders and Symptoms of ADHD
Deborah A. Pearson, Ph.D. University of Texas Medical School at Houston, Houston, TX
Cynthia W. Santos, M.D. University of Texas at Houston, Houston, TX
Charles Casat, M.D. Carolina NeuroSolutions, Charleston, SC
Michael Aman, Ph.D. The Ohio State University, Columbus, OH
L. Eugene Arnold, M.D. The Ohio State University, Sunbury, OH
Russell J. Schachar, M.D., FRCPC The Hospital for Sick Children, Toronto, ON
Susan Jerger, Ph.D. University of Texas at Dallas, Richardson, TX
Rosleen Mansour, M.A. University of Texas at Houston Medical School, Houston, TX
Katherine A. Loveland, Ph.D. University of Texas Medical School at Houston, Houston, TX
David Lane, Ph.D. Rice University, Houston, TX
Felecia Ingram Garner, M.D. University of Texas Medical School at Houston, Pearland, TX
Tanya Krolls, M.D. University of Texas Medical School at Houston, Houston, TX
Peter Ly, M.D. University of Texas Health Science Center at Houston, Houston, TX
Tu-Lan Dinh Nguyen, M.D. University of Texas Medical School at Houston, Houston, TX
Ashutosh Atri, M.D. University of Texas at Houston Medical School, Houston, TX
Justin Parrott, M.D. University of Texas Medical School at Houston, Houston, TX
Desirae Reeder, M.D. University of Texas at Houston Medical School, Houston, TX
Katie C. Roberts, M.D. University of Texas at Houston Medical School, Houston, TX
Sarah Ezzell, B.A. University of Texas at Houston Medical School, Houston, TX
Perry Factor, B.A. University of Texas at Houston Medical School, Houston, TX
Enstin Ye, B.A. University of Texas at Houston Medical School, Houston, TX
Walberto Resendez, B.S. University of Texas at Houston Medical School, Houston, TX
Punya Narain, B.A. University of Texas at Houston Medical School, Houston, TX
Lynne Cleveland, B.A. University of Texas at Houston Medical School, Houston, TX
 
2.50
Specialized Inpatient Psychiatry Units for Children with Autism and Developmental Disorders: A United States Survey
Matthew Siegel, M.D. Spring Harbor Hospital, Westbrook, ME
Kathleen Doyle, B.A. Mount Holyoke College, South Hadley, MA
Bruce Chemelski, Ph.D. Spring Harbor Hospital, Westbrook, ME
David A. Payne Spring Harbor Hospital, Westbrook, ME
Beth Ellsworth, M.A. Spring Harbor Hospital, Westbrook, ME
Jamie Harmon, O.T.R./L. Spring Harbor Hospital, Westbrook, ME
Douglas Robbins, M.D. Maine Medical Center, Portland, ME
Briana Milligan Spring Harbor Hospital, Westbrook, ME
Martin J. Lubetsky, M.D. Western Psychiatric Institute and Clinic, Pittsburgh, PA
 
2.52
Severe Psychopathology in Pediatric Epilepsy: Associated Functional Impairment and Risk Factors
Prabha Siddarth, Ph.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
Suresh G. Gurbani, M.D., Ph.D. Kaiser Permanente, Anaheim, CA
Rochelle Caplan, M.D. Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, Los Angeles, CA
 
2.53
Child Psychiatry Access Project: A Pilot Project in Maine
Sandra L. Fritsch, M.D. Maine Medical Center, Portland, ME
Neil Korsen, M.D., M.S. MaineHealth, Portland, ME
Nan M. Solomons, M.S. MaineHealth, Portland, ME
 
2.54
Recognition of Delirium on Pediatric Hospital Services
Patrick Kelly, M.D. The Johns Hopkins Hospital, Baltimore, MD
Emily Frosch, M.D. The Johns Hopkins Hospital, Baltimore, MD
 
2.55
Basic Science-Guided Coaching of Primary Care Providers
Peter S. Jensen, M.D. Mayo Clinic; The REACH Institute, New York, NY
 
2.56
Quality Management for Child and Adolescent Psychiatry Consultation Services in the Pediatric Hospital Setting
Katie A. Gallagher, M.A. Children's Hospital Boston, Boston, MA
Robert Li Kitts, M.D. Children's Hospital Boston, Boston, MA
Bradley L. Gerber, Ph.D. Children's Hospital Boston, Boston, MA
I. Simona Bujoreanu, Ph.D. Children's Hospital Boston, Boston, MA
Georgina E. Garcia, M.D. Children's Hospital Boston, Boston, MA
Patricia I. Ibeziako, M.D. Harvard Medical School, Children's Hospital Boston, Boston, MA
David R. DeMaso, M.D. Children's Hospital Boston, Boston, MA
 
2.57
Adoption and Use of a Statewide Program to Provide Point-of-Care Child Psychiatry Expertise and Referral Assistance to Primary Care Physicians
Jeanne Van Cleave, M.D. Massachusetts General Hospital for Children, Boston, MA
Bruce Masek, Ph.D. Massachusetts General Hospital, Boston, MA
Timothy G. Ferris, M.D., M.P.H. Massachusetts General Hospital, Boston, MA
James M. Perrin, M.D. Massachusetts General Hospital for Children, Boston, MA
 
2.58
Adolescent Depression and Suicide Risk Assessment: Training Pediatricians Using Standardized Patients
Elise M. Fallucco, M.D. Nemours Children's Clinic, Jacksonville, FL
Mary K. Conlon, M.D. New York University, New York, NY
Greg Gale, M.D. Beth Israel Medical Center, New York, NY
John N. Constantino, M.D. Washington University School of Medicine in St. Louis, Saint Louis, MO
Anne L. Glowinski, M.D., M.P.E. Washington University School of Medicine in St. Louis, Saint Louis, MO
 
2.59
Psychological and Behavioral Problems in Preschoolers with Allergic Diseases
Hyoungyoon Chang, M.D. Gangnam Severance Hospital, Yonsei University, College of Medicine, Seoul South Korea
Yee Jin Shin, M.D. Gangnam Severance Hospital, Yonsei University, College of Medicine, Seoul South Korea
Soo-Jong Hong, M.D., Ph.D. Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul South Korea
Ji-Won Kwon, M.D. Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul South Korea
Ju-Hee Sea, M.D. Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul South Korea
Dong-Ho Song, M.D., Ph.D. Severance Children's Hospital, Yosei University College of Medicine, Seoul South Korea
Keun-Ah Cheon, M.D., Ph.D. Severance Children's Hospital, Yosei University College of Medicine, Seoul South Korea
Kyungun Jhung, M.D. Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
So-Dam Kook, M.D. Gangnam Severance Hospital, Yonsei University, College of Medicine, Seoul South Korea
JeeIn Park, M.D. Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Jin-Kook Heo, M.D. Gangnam Severance Hospital, Yonsei University, College of Medicine, Seoul South Korea
 
2.60
Relationship of Intelligence with Health-Related Quality of Life (HRQOL), and Parental Stress, Satisfaction and Efficacy, in Children with Brain Tumors
Kyung Jin An, M.D. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul South Korea
Yoo- Sook Joung, M.D., Ph.D. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul South Korea
Ki Woong Sung, M.D., Ph.D. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul South Korea
Ji-Hae Kim, Ph.D. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul South Korea
See more of: New Research Poster